Publication | Closed Access
Kinase Dead BTK Mutations Confer Resistance to Covalent and Noncovalent BTK Inhibitors but Are Susceptible to Clinical Stage BTK Degraders
17
Citations
0
References
2022
Year
MedicineReceptor Tyrosine KinaseNoncovalent Btk InhibitorsPharmacologyRadiation OncologyNovel TherapyAre SusceptibleDrug Discovery
No additional data available for this publication yet. Check back later!